
AHPRA-registered telehealth consults and patient care plans. The clinical access layer of the pathway — connecting Australians to evidence-led practitioners.
Verteq is the parent group behind PLNTD and LeafyLabs — sister brands operating at each end of the same care pathway. Together they form one of Australia's most considered routes through alternative therapeutics, from first consultation to ongoing treatment.

The path to alternative treatment in Australia is still harder than it should be — for patients navigating eligibility, for doctors weighing evidence, for pharmacists managing dispensing.
Verteq exists to make that path clearer, safer, and held to a higher standard. We provide the governance, the brand stewardship, and the practitioner infrastructure that lets each of our operating brands stay focused on their patients and their clinicians.

Clinically. Ethically. End to end. Eligibility for any treatment is determined by your treating doctor — but the system around that decision should be the best it can possibly be.
Three pillars. One connected pathway.
Verteq sits above PLNTD and LeafyLabs — providing governance, shared clinical infrastructure, and the standards both brands operate under.
The result is a single pathway from patient consultation to pharmaceutical-grade dispensing, held to AHPRA, TGA SAS-B and ARTG standards at every step.
AHPRA-registered telehealth consultations and patient care plans.
Pharmaceutical-grade therapeutics, dispensed through accredited pharmacies.
Governance, partnerships, and shared clinical infrastructure across both brands.

AHPRA-registered telehealth consults and patient care plans. The clinical access layer of the pathway — connecting Australians to evidence-led practitioners.

Pharmaceutical-grade alternative therapeutics, supplied to doctors and pharmacists. The product layer — sourcing, standards, and dispensing support.
Verteq works directly with Australian doctors and pharmacists — providing product monographs, dispensing guidance, and a direct clinical line to PLNTD and LeafyLabs.